Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 366

1.

Dysfunction between dorsal caudate and salience network associated with impaired cognitive flexibility in obsessive-compulsive disorder: A resting-state fMRI study.

Tomiyama H, Nakao T, Murayama K, Nemoto K, Ikari K, Yamada S, Kuwano M, Hasuzawa S, Togao O, Hiwatashi A, Kanba S.

Neuroimage Clin. 2019 Sep 16;24:102004. doi: 10.1016/j.nicl.2019.102004. [Epub ahead of print]

2.

In Vitro Modeling of the Bipolar Disorder and Schizophrenia Using Patient-Derived Induced Pluripotent Stem Cells with Copy Number Variations of PCDH15 and RELN.

Ishii T, Ishikawa M, Fujimori K, Maeda T, Kushima I, Arioka Y, Mori D, Nakatake Y, Yamagata B, Nio S, Kato TA, Yang N, Wernig M, Kanba S, Mimura M, Ozaki N, Okano H.

eNeuro. 2019 Oct 17;6(5). pii: ENEURO.0403-18.2019. doi: 10.1523/ENEURO.0403-18.2019. Print 2019 Sep/Oct.

3.

NT-proBNP and Risk of Dementia in a General Japanese Elderly Population: The Hisayama Study.

Nagata T, Ohara T, Hata J, Sakata S, Furuta Y, Yoshida D, Honda T, Hirakawa Y, Ide T, Kanba S, Kitazono T, Tsutsui H, Ninomiya T.

J Am Heart Assoc. 2019 Sep 3;8(17):e011652. doi: 10.1161/JAHA.118.011652. Epub 2019 Aug 24.

4.

Cuprizone-treated mice, a possible model of schizophrenia, highlighting the simultaneous abnormalities of GABA, serine and glycine in hippocampus.

Hayakawa E, Ohgidani M, Fujimura Y, Kanba S, Miura D, Kato TA.

Schizophr Res. 2019 Aug;210:326-328. doi: 10.1016/j.schres.2019.06.010. Epub 2019 Jul 8. No abstract available.

PMID:
31296416
5.

Clarifying Deeper Psychological Characteristics of Hikikomori Using the Rorschach Comprehensive System: A Pilot Case-Control Study.

Katsuki R, Inoue A, Indias S, Kurahara K, Kuwano N, Funatsu F, Kubo H, Kanba S, Kato TA.

Front Psychiatry. 2019 Jun 13;10:412. doi: 10.3389/fpsyt.2019.00412. eCollection 2019.

6.

Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression.

Kanba S, Murasaki M, Koyama T, Takeuchi M, Shimizu Y, Arita E, Kuroishi K, Takeuchi M, Kamei S.

BMC Psychiatry. 2019 Jun 26;19(1):198. doi: 10.1186/s12888-019-2181-9.

7.

Cannabis use correlates with aggressive behavior and long-acting injectable antipsychotic treatment in Asian patients with schizophrenia.

Park SC, Oh HS, Tripathi A, Kallivayalil RA, Avasthi A, Grover S, Tanra AJ, Kanba S, Kato TA, Inada T, Chee KY, Chong MY, Lin SK, Sim K, Xiang YT, Tan CH, Javed A, Sartorius N, Shinfuku N, Park YC.

Nord J Psychiatry. 2019 Aug;73(6):323-330. doi: 10.1080/08039488.2019.1632381. Epub 2019 Jun 26.

PMID:
31240984
8.

Hikikomori : Multidimensional understanding, assessment, and future international perspectives.

Kato TA, Kanba S, Teo AR.

Psychiatry Clin Neurosci. 2019 Aug;73(8):427-440. doi: 10.1111/pcn.12895. Epub 2019 Jun 24.

PMID:
31148350
9.

Pathophysiology and treatment of hoarding disorder.

Nakao T, Kanba S.

Psychiatry Clin Neurosci. 2019 Jul;73(7):370-375. doi: 10.1111/pcn.12853. Epub 2019 May 20.

PMID:
31021515
10.

Progressive reduction of auditory evoked gamma in first episode schizophrenia but not clinical high risk individuals.

Oribe N, Hirano Y, Del Re E, Seidman LJ, Mesholam-Gately RI, Woodberry KA, Wojcik JD, Ueno T, Kanba S, Onitsuka T, Shenton ME, Goldstein JM, Niznikiewicz MA, McCarley RW, Spencer KM.

Schizophr Res. 2019 Jun;208:145-152. doi: 10.1016/j.schres.2019.03.025. Epub 2019 Apr 17.

PMID:
31005464
11.

Development and validation of the 22-item Tarumi's Modern-Type Depression Trait Scale: Avoidance of Social Roles, Complaint, and Low Self-Esteem (TACS-22).

Kato TA, Katsuki R, Kubo H, Shimokawa N, Sato-Kasai M, Hayakawa K, Kuwano N, Umene-Nakano W, Tateno M, Setoyama D, Kang D, Watabe M, Sakamoto S, Teo AR, Kanba S.

Psychiatry Clin Neurosci. 2019 Aug;73(8):448-457. doi: 10.1111/pcn.12842. Epub 2019 Apr 29.

PMID:
30900331
12.

Suicide and Microglia: Recent Findings and Future Perspectives Based on Human Studies.

Suzuki H, Ohgidani M, Kuwano N, Chrétien F, Lorin de la Grandmaison G, Onaya M, Tominaga I, Setoyama D, Kang D, Mimura M, Kanba S, Kato TA.

Front Cell Neurosci. 2019 Feb 13;13:31. doi: 10.3389/fncel.2019.00031. eCollection 2019.

13.

Psychotropic drug-prescribing correlates of disorganized speech in Asians with schizophrenia: The REAP-AP study.

Park YC, Lee MS, Si TM, Chiu HFK, Kanba S, Chong MY, Tripathi A, Udomratn P, Chee KY, Tanra AJ, Rabbani G, Javed A, Kathiarachchi S, Myint WA, Cuong TV, Sim K, Yang SY, Sartorius N, Tan CH, Shinfuku N, Park SC.

Saudi Pharm J. 2019 Feb;27(2):246-253. doi: 10.1016/j.jsps.2018.11.006. Epub 2018 Nov 13.

14.

Neuroanatomical substrate of chronic psychosis in epilepsy: an MRI study.

Hirakawa N, Kuga H, Hirano Y, Sato J, Oribe N, Nakamura I, Hirano S, Ueno T, Oda Y, Togao O, Hiwatashi A, Honda H, Kanba S, Onitsuka T.

Brain Imaging Behav. 2019 Feb 8. doi: 10.1007/s11682-019-00044-4. [Epub ahead of print]

PMID:
30734915
15.

Concurrent antipsychotic use in older adults treated with antidepressants in Asia.

Dong M, Zeng LN, Zhang Q, Ungvari GS, Ng CH, Chiu HFK, Si TM, Sim K, Avasthi A, Grover S, Chong MY, Chee KY, Kanba S, Lee MS, Yang SY, Udomratn P, Kallivayalil RA, Tanra AJ, Maramis MM, Shen WW, Sartorius N, Mahendran R, Tan CH, Shinfuku N, Xiang YT.

Psychogeriatrics. 2019 Jul;19(4):333-339. doi: 10.1111/psyg.12416. Epub 2019 Feb 7.

PMID:
30734411
16.

Making psychiatry a clinical neuroscience-based medicine.

Kato T, Kanba S.

Psychiatry Clin Neurosci. 2019 Jan;73(1):1. doi: 10.1111/pcn.12798. No abstract available.

PMID:
30609238
17.

Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders.

Reed GM, First MB, Kogan CS, Hyman SE, Gureje O, Gaebel W, Maj M, Stein DJ, Maercker A, Tyrer P, Claudino A, Garralda E, Salvador-Carulla L, Ray R, Saunders JB, Dua T, Poznyak V, Medina-Mora ME, Pike KM, Ayuso-Mateos JL, Kanba S, Keeley JW, Khoury B, Krasnov VN, Kulygina M, Lovell AM, de Jesus Mari J, Maruta T, Matsumoto C, Rebello TJ, Roberts MC, Robles R, Sharan P, Zhao M, Jablensky A, Udomratn P, Rahimi-Movaghar A, Rydelius PA, Bährer-Kohler S, Watts AD, Saxena S.

World Psychiatry. 2019 Feb;18(1):3-19. doi: 10.1002/wps.20611.

18.

Development of MHFA-based 2-h educational program for early intervention in depression among office workers: A single-arm pilot trial.

Kubo H, Urata H, Katsuki R, Hirashima M, Ueno S, Suzuki Y, Fujisawa D, Hashimoto N, Kobara K, Cho T, Mitsui T, Kanba S, Otsuka K, Kato TA.

PLoS One. 2018 Dec 7;13(12):e0208114. doi: 10.1371/journal.pone.0208114. eCollection 2018.

19.

Decline in handgrip strength from midlife to late-life is associated with dementia in a Japanese community: the Hisayama Study.

Hatabe Y, Shibata M, Ohara T, Oishi E, Yoshida D, Honda T, Hata J, Kanba S, Kitazono T, Ninomiya T.

J Epidemiol. 2018 Dec 8. doi: 10.2188/jea.JE20180137. [Epub ahead of print]

20.

Serum Soluble Triggering Receptor Expressed on Myeloid Cells 2 as a Biomarker for Incident Dementia: The Hisayama Study.

Ohara T, Hata J, Tanaka M, Honda T, Yamakage H, Yoshida D, Inoue T, Hirakawa Y, Kusakabe T, Shibata M, Teraoka T, Kitazono T, Kanba S, Satoh-Asahara N, Ninomiya T.

Ann Neurol. 2019 Jan;85(1):47-58. doi: 10.1002/ana.25385. Epub 2018 Dec 28.

PMID:
30485483
21.

Revising Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project.

Parker G, Tavella G, Macqueen G, Berk M, Grunze H, Deckersbach T, Dunner DL, Sajatovic M, Amsterdam JD, Ketter TA, Yatham LN, Kessing LV, Bassett D, Zimmerman M, Fountoulakis KN, Duffy A, Alda M, Calkin C, Sharma V, Anand A, Singh MK, Hajek T, Boyce P, Frey BN, Castle DJ, Young AH, Vieta E, Rybakowski JK, Swartz HA, Schaffer A, Murray G, Bayes A, Lam RW, Bora E, Post RM, Ostacher MJ, Lafer B, Cleare AJ, Burdick KE, O'Donovan C, Ortiz A, Henry C, Kanba S, Rosenblat JD, Parikh SV, Bond DJ, Grunebaum MF, Frangou S, Goldberg JF, Orum M, Osser DN, Frye MA, McIntyre RS, Fagiolini A, Manicavasagar V, Carlson GA, Malhi GS.

Aust N Z J Psychiatry. 2018 Oct 31:4867418808382. doi: 10.1177/0004867418808382. [Epub ahead of print]

PMID:
30378461
22.

Differences in High Dose Antipsychotic Prescriptions in Patients with Schizophrenia in Asian Countries/Areas: Findings from the REAP-AP Study.

Park YC, Yang SY, Chong MY, Kanba S, Sartorius N, Shinfuku N, Tan CH, Park SC.

Psychiatry Investig. 2018 Oct;15(10):1007-1008. doi: 10.30773/pi.2018.09.06. Epub 2018 Oct 22.

23.

Correction to: Multi-center, randomized, double-blind, placebocontrolled study of quetiapine extended-release formulation in Japanese patients with bipolar depression.

Murasaki M, Koyama T, Kanba S, Takeuchi M, Shimizu Y, Arita E, Kuroishi K, Takeuchi M, Kamei S.

Psychopharmacology (Berl). 2018 Oct;235(10):3079-3080. doi: 10.1007/s00213-018-5013-6.

PMID:
30221314
24.

Clinical utility of ICD-11 diagnostic guidelines for high-burden mental disorders: results from mental health settings in 13 countries.

Reed GM, Keeley JW, Rebello TJ, First MB, Gureje O, Ayuso-Mateos JL, Kanba S, Khoury B, Kogan CS, Krasnov VN, Maj M, de Jesus Mari J, Sharan P, Stein DJ, Zhao M, Akiyama T, Andrews HF, Asevedo E, Cheour M, Domínguez-Martínez T, El-Khoury J, Fiorillo A, Grenier J, Gupta N, Kola L, Kulygina M, Leal-Leturia I, Luciano M, Lusu B, Martínez-López JNI, Matsumoto C, Odunleye M, Onofa LU, Paterniti S, Purnima S, Robles R, Sahu MK, Sibeko G, Zhong N, Gaebel W, Lovell AM, Maruta T, Pike KM, Roberts MC, Medina-Mora ME.

World Psychiatry. 2018 Oct;17(3):306-315. doi: 10.1002/wps.20581.

25.

Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression.

Murasaki M, Koyama T, Kanba S, Takeuchi M, Shimizu Y, Arita E, Kuroishi K, Takeuchi M, Kamei S.

Psychopharmacology (Berl). 2018 Oct;235(10):2859-2869. doi: 10.1007/s00213-018-4977-6. Epub 2018 Aug 1. Erratum in: Psychopharmacology (Berl). 2018 Sep 17;:.

26.

Neuron-related blood inflammatory markers as an objective evaluation tool for major depressive disorder: An exploratory pilot case-control study.

Kuwano N, Kato TA, Mitsuhashi M, Sato-Kasai M, Shimokawa N, Hayakawa K, Ohgidani M, Sagata N, Kubo H, Sakurai T, Kanba S.

J Affect Disord. 2018 Nov;240:88-98. doi: 10.1016/j.jad.2018.07.040. Epub 2018 Jul 17.

PMID:
30059939
27.

Postgraduate training in psychiatry in Asia.

Isaac M, Ahmed HU, Chaturvedi SK, Hopwood MJ, Javeed A, Kanba S, Mufti AA, Maramis A, Samaniego RM, Udomratn P, Yanling H, Zainal NZ, Sartorius N.

Curr Opin Psychiatry. 2018 Sep;31(5):396-402. doi: 10.1097/YCO.0000000000000444.

PMID:
30015670
28.

A unique increase in prefrontal gray matter volume in hoarding disorder compared to obsessive-compulsive disorder.

Yamada S, Nakao T, Ikari K, Kuwano M, Murayama K, Tomiyama H, Hasuzawa S, Togao O, Hiwatashi A, Kanba S.

PLoS One. 2018 Jul 16;13(7):e0200814. doi: 10.1371/journal.pone.0200814. eCollection 2018.

29.

Physical comorbidities in older adults receiving antidepressants in Asia.

Zhong XM, Dong M, Wang F, Zhang Q, Ungvari GS, Ng CH, Chiu HFK, Si TM, Sim K, Avasthi A, Grover S, Chong MY, Chee KY, Kanba S, Lee MS, Yang SY, Udomratn P, Kallivayalil RA, Tanra AJ, Maramis MM, Shen WW, Sartorius N, Mahendran R, Tan CH, Shinfuku N, Xiang YT.

Psychogeriatrics. 2018 Sep;18(5):351-356. doi: 10.1111/psyg.12327. Epub 2018 Jul 10.

PMID:
29989257
30.

Development and validation of the 25-item Hikikomori Questionnaire (HQ-25).

Teo AR, Chen JI, Kubo H, Katsuki R, Sato-Kasai M, Shimokawa N, Hayakawa K, Umene-Nakano W, Aikens JE, Kanba S, Kato TA.

Psychiatry Clin Neurosci. 2018 Oct;72(10):780-788. doi: 10.1111/pcn.12691. Epub 2018 Jul 27. Erratum in: Psychiatry Clin Neurosci. 2019 Sep;73(9):603.

31.

Association Between Daily Sleep Duration and Risk of Dementia and Mortality in a Japanese Community.

Ohara T, Honda T, Hata J, Yoshida D, Mukai N, Hirakawa Y, Shibata M, Kishimoto H, Kitazono T, Kanba S, Ninomiya T.

J Am Geriatr Soc. 2018 Oct;66(10):1911-1918. doi: 10.1111/jgs.15446. Epub 2018 Jun 6.

PMID:
29873398
32.

The ICD-11 developmental field study of reliability of diagnoses of high-burden mental disorders: results among adult patients in mental health settings of 13 countries.

Reed GM, Sharan P, Rebello TJ, Keeley JW, Elena Medina-Mora M, Gureje O, Luis Ayuso-Mateos J, Kanba S, Khoury B, Kogan CS, Krasnov VN, Maj M, de Jesus Mari J, Stein DJ, Zhao M, Akiyama T, Andrews HF, Asevedo E, Cheour M, Domínguez-Martínez T, El-Khoury J, Fiorillo A, Grenier J, Gupta N, Kola L, Kulygina M, Leal-Leturia I, Luciano M, Lusu B, Nicolas J, Martínez-López I, Matsumoto C, Umukoro Onofa L, Paterniti S, Purnima S, Robles R, Sahu MK, Sibeko G, Zhong N, First MB, Gaebel W, Lovell AM, Maruta T, Roberts MC, Pike KM.

World Psychiatry. 2018 Jun;17(2):174-186. doi: 10.1002/wps.20524.

33.

Neurocognitive disorders in ICD-11: the debate and its outcome.

Gaebel W, Jessen F, Kanba S.

World Psychiatry. 2018 Jun;17(2):229-230. doi: 10.1002/wps.20534. No abstract available.

34.

Association between the ratio of serum arachidonic acid to eicosapentaenoic acid and the presence of depressive symptoms in a general Japanese population: the Hisayama Study.

Shibata M, Ohara T, Yoshida D, Hata J, Mukai N, Kawano H, Kanba S, Kitazono T, Ninomiya T.

J Affect Disord. 2018 Sep;237:73-79. doi: 10.1016/j.jad.2018.05.004. Epub 2018 May 14.

PMID:
29787929
35.

Is a Socio-Cultural Analysis of Depressive Disorders a Matter of Concern? Response to Kaiya.

Kato TA, Kanba S.

Am J Psychiatry. 2018 May 1;175(5):483-484. doi: 10.1176/appi.ajp.2018.17121404r. No abstract available.

PMID:
29712479
36.

Early-onset epileptic encephalopathy and severe developmental delay in an association with de novo double mutations in NF1 and MAGEL2.

Akamine S, Sagata N, Sakai Y, Kato TA, Nakahara T, Matsushita Y, Togao O, Hiwatashi A, Sanefuji M, Ishizaki Y, Torisu H, Saitsu H, Matsumoto N, Hara T, Sawa A, Kano S, Furue M, Kanba S, Shaw CA, Ohga S.

Epilepsia Open. 2017 Nov 23;3(1):81-85. doi: 10.1002/epi4.12085. eCollection 2018 Mar.

37.

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, Alda M, MacQueen G, Milev RV, Ravindran A, O'Donovan C, McIntosh D, Lam RW, Vazquez G, Kapczinski F, McIntyre RS, Kozicky J, Kanba S, Lafer B, Suppes T, Calabrese JR, Vieta E, Malhi G, Post RM, Berk M.

Bipolar Disord. 2018 Mar;20(2):97-170. doi: 10.1111/bdi.12609. Epub 2018 Mar 14.

38.

Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.

Kuwano N, Kato TA, Setoyama D, Sato-Kasai M, Shimokawa N, Hayakawa K, Ohgidani M, Sagata N, Kubo H, Kishimoto J, Kang D, Kanba S.

J Affect Disord. 2018 Apr 15;231:74-82. doi: 10.1016/j.jad.2018.01.014. Epub 2018 Jan 31.

PMID:
29454180
39.

p66Shc Signaling Mediates Diabetes-Related Cognitive Decline.

Minami Y, Sonoda N, Hayashida E, Makimura H, Ide M, Ikeda N, Ohgidani M, Kato TA, Seki Y, Maeda Y, Kanba S, Takayanagi R, Ogawa Y, Inoguchi T.

Sci Rep. 2018 Feb 16;8(1):3213. doi: 10.1038/s41598-018-21426-6.

40.

Blood biomarkers of Hikikomori, a severe social withdrawal syndrome.

Hayakawa K, Kato TA, Watabe M, Teo AR, Horikawa H, Kuwano N, Shimokawa N, Sato-Kasai M, Kubo H, Ohgidani M, Sagata N, Toda H, Tateno M, Shinfuku N, Kishimoto J, Kanba S.

Sci Rep. 2018 Feb 13;8(1):2884. doi: 10.1038/s41598-018-21260-w.

41.

To use the brief psychiatric rating scale to detect disorganized speech in schizophrenia: Findings from the REAP-AP study.

Chon Park Y, Kanba S, Chong MY, Tripathi A, Kallivayalil RA, Avasthi A, Grover S, Chee KY, J Tanra A, Maramis MM, Yang SY, Sartorius N, Tan CH, Shinfuku N, Park SC.

Kaohsiung J Med Sci. 2018 Feb;34(2):113-119. doi: 10.1016/j.kjms.2017.09.009. Epub 2017 Oct 20.

42.

Phase-Amplitude Coupling of the Electroencephalogram in the Auditory Cortex in Schizophrenia.

Hirano S, Nakhnikian A, Hirano Y, Oribe N, Kanba S, Onitsuka T, Levin M, Spencer KM.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Jan;3(1):69-76. doi: 10.1016/j.bpsc.2017.09.001. Epub 2017 Sep 13.

PMID:
29397081
43.

Hikikomori: experience in Japan and international relevance.

Kato TA, Kanba S, Teo AR.

World Psychiatry. 2018 Feb;17(1):105-106. doi: 10.1002/wps.20497. No abstract available.

44.

Concurrent benzodiazepine use in older adults treated with antidepressants in Asia.

Zhong XM, Wang F, Zhang Q, Ungvari GS, Ng CH, Chiu HFK, Si TM, Sim K, Avasthi A, Grover S, Chong MY, Chee KY, Kanba S, Lee MS, Yang SY, Udomratn P, Kallivayalil RA, Tanra AJ, Maramis MM, Shen WW, Sartorius N, Mahendran R, Tan CH, Shinfuku N, Xiang YT.

Int Psychogeriatr. 2019 May;31(5):685-691. doi: 10.1017/S1041610217002563. Epub 2017 Dec 7.

PMID:
29212560
45.

Modern-Type Depression as an "Adjustment" Disorder in Japan: The Intersection of Collectivistic Society Encountering an Individualistic Performance-Based System.

Kato TA, Kanba S.

Am J Psychiatry. 2017 Nov 1;174(11):1051-1053. doi: 10.1176/appi.ajp.2017.17010059. No abstract available.

PMID:
29088934
46.

Dysregulated gene expressions of MEX3D, FOS and BCL2 in human induced-neuronal (iN) cells from NF1 patients: a pilot study.

Sagata N, Kato TA, Kano SI, Ohgidani M, Shimokawa N, Sato-Kasai M, Hayakawa K, Kuwano N, Wilson AM, Ishizuka K, Kato S, Nakahara T, Nakahara-Kido M, Setoyama D, Sakai Y, Ohga S, Furue M, Sawa A, Kanba S.

Sci Rep. 2017 Oct 24;7(1):13905. doi: 10.1038/s41598-017-14440-7.

47.

Survey on attitudes towards renaming bipolar disorder in Japanese.

Kato T, Kanba S.

Psychiatry Clin Neurosci. 2018 Jan;72(1):45. doi: 10.1111/pcn.12610. Epub 2017 Nov 9. No abstract available.

48.

Fibromyalgia and microglial TNF-α: Translational research using human blood induced microglia-like cells.

Ohgidani M, Kato TA, Hosoi M, Tsuda M, Hayakawa K, Hayaki C, Iwaki R, Sagata N, Hashimoto R, Inoue K, Sudo N, Kanba S.

Sci Rep. 2017 Sep 19;7(1):11882. doi: 10.1038/s41598-017-11506-4.

49.

[Translational Research on Neuropsychiatric Disorders: Focusing on Microglia Hypothesis].

Kato TA, Ohgidani M, Kanba S.

Brain Nerve. 2017 Sep;69(9):1007-1015. doi: 10.11477/mf.1416200860. Japanese.

PMID:
28900063
50.

Development of a 2-h suicide prevention program for medical staff including nurses and medical residents: A two-center pilot trial.

Nakagami Y, Kubo H, Katsuki R, Sakai T, Sugihara G, Naito C, Oda H, Hayakawa K, Suzuki Y, Fujisawa D, Hashimoto N, Kobara K, Cho T, Kuga H, Takao K, Kawahara Y, Matsumura Y, Murai T, Akashi K, Kanba S, Otsuka K, Kato TA.

J Affect Disord. 2018 Jan 1;225:569-576. doi: 10.1016/j.jad.2017.08.074. Epub 2017 Aug 30.

PMID:
28886497

Supplemental Content

Support Center